Next-Generation Sequencing for Typing and Detection of Resistance Genes: Performance of a New Commercial Method during an Outbreak of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli

ABSTRACT Next-generation sequencing (NGS) has the potential to provide typing results and detect resistance genes in a single assay, thus guiding timely treatment decisions and allowing rapid tracking of transmission of resistant clones. We evaluated the performance of a new NGS assay (Hospital Acquired Infection BioDetection System; Pathogenica) during an outbreak of sequence type 131 (ST131) Escherichia coli infections in a nursing home in The Netherlands. The assay was performed on 56 extended-spectrum-beta-lactamase (ESBL) E. coli isolates collected during 2 prevalence surveys (March and May 2013). Typing results were compared to those of amplified fragment length polymorphism (AFLP), whereby we visually assessed the agreement of the BioDetection phylogenetic tree with clusters defined by AFLP. A microarray was considered the gold standard for detection of resistance genes. AFLP identified a large cluster of 31 indistinguishable isolates on adjacent departments, indicating clonal spread. The BioDetection phylogenetic tree showed that all isolates of this outbreak cluster were strongly related, while the further arrangement of the tree also largely agreed with other clusters defined by AFLP. The BioDetection assay detected ESBL genes in all but 1 isolate (sensitivity, 98%) but was unable to discriminate between ESBL and non-ESBL TEM and SHV beta-lactamases or to specify CTX-M genes by group. The performance of the hospital-acquired infection (HAI) BioDetection System for typing of E. coli isolates compared well with the results of AFLP. Its performance with larger collections from different locations, and for typing of other species, was not evaluated and needs further study.

[1]  N. Woodford,et al.  CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.

[2]  J. Wain,et al.  Improved Multiplex PCR Strategy for Rapid Assignment of the Four Major Escherichia coli Phylogenetic Groups , 2012, Journal of Clinical Microbiology.

[3]  W. Bilker,et al.  Colonization with Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species in Long-Term Care Facility Residents , 2012, Infection Control & Hospital Epidemiology.

[4]  Tommi S. Jaakkola,et al.  Fast optimal leaf ordering for hierarchical clustering , 2001, ISMB.

[5]  E Feil,et al.  Guidelines for the validation and application of typing methods for use in bacterial epidemiology. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  L. Strausbaugh,et al.  Antimicrobial Resistance in Long-Term–Care Facilities , 1996, Infection Control & Hospital Epidemiology.

[7]  P. Nordmann,et al.  Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). , 2012, The Journal of antimicrobial chemotherapy.

[8]  G. Rossolini,et al.  The spread of CTX-M-type extended-spectrum β-lactamases , 2008 .

[9]  J. Quinn,et al.  Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009 , 2012, Antimicrobial Agents and Chemotherapy.

[10]  E. Denamur,et al.  The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. , 2013, Environmental microbiology reports.

[11]  Daniel Falush,et al.  Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.

[12]  B. Duim,et al.  Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. , 2010, The Journal of antimicrobial chemotherapy.

[13]  P. A. Rolfe,et al.  Rapid Resistome Fingerprinting and Clonal Lineage Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates by Targeted Next-Generation Sequencing , 2014, Journal of Clinical Microbiology.

[14]  P. Savelkoul,et al.  Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands , 2011, Emerging infectious diseases.

[15]  A. Safdar.  Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Bidochka,et al.  Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. , 1998, Canadian journal of microbiology.

[17]  A. Friedrich,et al.  Overview of molecular typing methods for outbreak detection and epidemiological surveillance. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  Neil Woodford,et al.  Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases. , 2010, International journal of antimicrobial agents.

[19]  Alexandros Stamatakis,et al.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models , 2006, Bioinform..

[20]  H. Reesink,et al.  Amplified‐fragment length polymorphism analysis of Propionibacterium isolates implicated in contamination of blood products , 2005, British journal of haematology.

[21]  F. Baquero,et al.  Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.